CNE100003308
CNE100003308
PHARSCIN PHARMA
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 827.144.563 | 774.819.867 | 6.8% |
| Cost of Revenue | 352.473.143 | 331.050.582 | 6.5% |
| Gross Profit | 474.671.420 | 443.769.284 | 7.0% |
| 405.052.108 | 358.668.059 | 12.9% | |
| Operating Income | 69.619.312 | 85.101.226 | 18.2% |
| Pretax Income | 77.456.538 | 93.441.939 | 17.1% |
| Net Income Common Stockholders | 65.086.781 | 76.730.225 | 15.2% |
| -- | -- | -- | |
| -- | -- | -- |